Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2010
03/17/2010EP2163553A1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
03/17/2010EP2162448A1 Isothiazole and pyrazole derivatives as fungicides
03/17/2010EP2162445A1 Heterobicyclic compounds as kinase inhibitors
03/17/2010EP2162436A1 Novel case of renin inhibitors
03/17/2010EP1928869B1 Chemical process
03/17/2010EP1713822B1 Hcv ns-3 serine protease inhibitors
03/17/2010EP1654257B1 Aminopyrones and their use as atm inhibitors
03/17/2010EP1620411B1 Inhibitors of akt activity
03/17/2010EP1513814B1 Novel piperidine compound
03/17/2010CN101675046A therapeutic agents
03/17/2010CN101675045A Hetarylanilines as modulators for amyloid beta
03/17/2010CN101675041A Aminopyrimidines useful as kinase inhibitors
03/17/2010CN101674727A Pyridonecarboxamides crop protection agents containing the same method for production and use thereof
03/17/2010CN101671335A Cytotoxins, prodrugs, linkers and stabilizers useful therefor
03/17/2010CN101671307A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
03/17/2010CN100594214C Substituted oxazolobenzoisothiazole dioxide derivatives, production method and use thereof
03/16/2010US7680601 Generating antibiotic; transforming cell with expression vector coding polyketide synthase; computational analysis of polyketides and computer-assisted design of PKS genes are facilitated by representing structure of polyketide and/or PKS gene that encodes PKS that produces polyketide
03/16/2010US7678916 crystalline rosiglitazone maleate filtration
03/16/2010US7678902 Reacting 2,2'-dithiosalicylic acid with 1-chloro-2-nitrobenzene in basic aqueous solution, conducting nitro group reduction reaction, simultaneously cyclizing and chlorinating in solvent, and halogenating; environmentally friendly, cost efficiency
03/16/2010US7678815 Thiazole-4-carboxyamide derivatives
03/16/2010US7678813 8a-Benzyl-2-(4-methoxyphenyl)-1,3,4,7,8,8a-hexahydro-2H-isoquinolin-6-one; psychotic major depression, schizoaffective disorder, Alzheimer's Disease and cocaine addiction
03/16/2010US7678810 activin receptor-like kinase 5 (ALK5) (which is a TGF- beta type I receptor) inhibitor ; glomerulonephritis, diabetic nephropathy, hepatic fibrosis, liver cirrhosis, pulmonary fibrosis, or alopeciarosis; hair growth stimulant
03/16/2010US7678802 Voltage gated sodium and calcium channel inhibitors
03/16/2010US7678799 Crystalline ziprasidone HCl and processes for preparation thereof
03/16/2010US7678798 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
03/16/2010US7678796 MGluR5 modulators I
03/16/2010US7678790 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents
03/16/2010US7678789 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and NADPH quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
03/16/2010US7678474 Imidazole derivatives and organic electronic device using the same
03/16/2010CA2386980C Benzodiazepine derivatives for use in acute or chronic neurological disorders
03/16/2010CA2336846C Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric g protein
03/11/2010WO2010028338A2 Novel compounds as cannabinoid receptor ligands
03/11/2010WO2010028179A1 Heterocyclic compounds as gata modulators
03/11/2010WO2010027564A2 Amido anti-viral compounds, compositions, and methods of use
03/11/2010WO2010027051A1 Substituted acetophenone compound, process for producing same, and use of same
03/11/2010WO2010026972A1 Polymer compound and polymer light-emitting element utilizing same
03/11/2010WO2010026771A1 Nitrogenated heterocyclic compound and salt thereof, and bactericidal agent for agricultural or horticultural applications
03/11/2010WO2010026365A1 N-myristoyl transferase inhibitors
03/11/2010WO2010026212A1 Novel inhibitors
03/11/2010WO2010026121A1 Bicyclic kinase inhibitors
03/11/2010WO2010025856A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
03/11/2010WO2010025553A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2010WO2009156099A8 6-substituted isoquinolines and isoquinolinones
03/11/2010WO2009118567A3 Pyrimidines, triazines and their use as kinase inhibitors
03/11/2010US20100063109 Thiadiazolidinone derivatives
03/11/2010US20100063108 Pyridin-4-yl derivatives as immunomodulating agents
03/11/2010US20100063088 Raf Kinase Inhibitors
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063078 Spirocompounds useful as modulators for dopamine d3 receptors
03/11/2010US20100063075 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
03/11/2010US20100063056 Bipyridine carboxamide orexin receptor antagonists
03/11/2010US20100063051 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/11/2010US20100063045 Novel pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure
03/11/2010US20100063037 6-substituted benzoxazines
03/11/2010US20100063036 Substituted morpholine and thiomorpholine derivatives
03/11/2010US20100063033 administering (2,6-Dimethyl-4-morpholin-4-yl-phenyl)-carbamic acid butyl ester, for the treatment of bipolar disorders, seizure disorders, anxiety disorders, neuropathic pain and migraine pain disorders or neurodegenerative disorders
03/11/2010US20100063026 Antibacterial quinoline derivatives
03/11/2010US20100063024 Dihydropyrazolopyrimidinone Derivatives
03/11/2010US20100063022 Novel compounds as cannabinoid receptor ligands
03/11/2010US20100062942 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
03/11/2010US20100062470 Luminogenic compounds and methods to detect cytochrome p450 3a enzymes
03/11/2010US20100061960 Amido Anti-Viral Compounds, Compositions, And Methods Of Use
03/11/2010CA2735842A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
03/11/2010CA2735795A1 Novel inhibitors
03/11/2010CA2735794A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2010CA2735779A1 Bicyclic kinase inhibitors
03/11/2010CA2735775A1 6-substituted benzoxazines
03/11/2010CA2734527A1 Novel compounds as cannabinoid receptor ligands
03/11/2010CA2733533A1 Hedgehog pathway modulators
03/10/2010EP2161258A2 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
03/10/2010EP2160380A1 Cyano-guanidine derivatives as glutaminyl cyclase inhibitors
03/10/2010EP1896456B1 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
03/10/2010EP1841737B1 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands
03/10/2010EP1765816B1 Substituted 1-propiolylpiperazines having an affinity for the mglur5 receptor in order to treat painful conditions
03/10/2010EP1751113B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/09/2010US7674887 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
03/09/2010US7674828 Urea antagonists of P2Y1receptor useful in the treatment of thrombotic conditions
03/09/2010US7674823 DNA-PK inhibitors
03/09/2010US7674818 Aryl, aryloxy, alkyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
03/09/2010US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
03/09/2010US7674806 Amidines and derivatives thereof and pharmaceutical compositions containing them
03/09/2010US7674803 Thiazolypiperidine derivatives as MTP inhibitors
03/09/2010US7674796 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one
03/09/2010US7674792 for treatment of deficiencies in hematopoietic cells
03/09/2010US7674788 7-amino-6-chloro-2-piperazin-1-yl-4-pyrrolidin-1-yl-pteridine; central nervous system, respiratory, gastrointestinal or inflammatory diseases; joints, skin or eyes diseases; cancer; phosphodiesterase 4 inhibitors
03/09/2010CA2537598C Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
03/09/2010CA2493313C Novel benzodioxoles
03/09/2010CA2482346C Substituted phenylacetamides and their use as glucokinase activators
03/09/2010CA2399813C Indol-3-yl derivatives
03/09/2010CA2329292C A process for the manufacture of sulfonylaminocarbonyl triazolinones and salts thereof under ph controlled conditions
03/09/2010CA2140598C Prolineamide derivatives
03/04/2010WO2010025235A1 Selective ligands for the dopamine 3 (d3) receptor and methods of using the same
03/04/2010WO2010024783A1 Biarylrhodanine and pyridylrhodanine compounds and their use
03/04/2010WO2010024227A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent
03/04/2010WO2010023946A1 Novel uracil compound having nitrogenated heterocyclic ring or salt thereof
03/04/2010WO2010023609A1 Oxazole, oxadiazole and thiazole derivatives as diacylglycerol acyltranferase inhibitors
03/04/2010WO2009153285A3 1,2-benzisothiazole compounds useful for combating animal pests
03/04/2010WO2009010478A3 Use of piperidine derivatives as agonists of chemokine receptor activity
03/04/2010US20100056583 Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation
03/04/2010US20100056582 Modulators of LXR
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 628